Clinical Trial Update: Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain [Phase 3]

View source ↗

Summary

This document updates the subject information and consent form for a Phase 3 trial comparing duloxetine once-daily dosing to placebo in adults with major depres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression, Pain | Phase 3 | Status: COMPLETED